Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachna Murthy

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Eye (London, England)|February 14, 2019
Sirolimus (rapamycin) for the targeted treatment of the fibrotic sequelae of Graves' orbitopathyJonathan C P Roos, Rachna Murthy
Eye (London, England)|December 14, 2018
Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United KingdomJonathan C P Roos, Rachna Murthy
Korean Journal of Ophthalmology : KJO|April 20, 2023
Thyrotropin Receptor Autoantibody Assessment in Thyroid Eye Disease: Does the Assay Type Matter?Malik Moledina, Jonathan Roos, Rachna Murthy
Current Opinion in Ophthalmology|July 18, 2019
Update on the clinical assessment and management of thyroid eye diseaseJonathan C P Roos, Rachna Murthy
Eye (London, England)|November 8, 2018
Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomyJonathan C P Roos, Vignesh Paulpandian, Rachna Murthy
Ophthalmic Plastic and Reconstructive Surgery|November 25, 2020
Inhibition of Fibrotic Contraction by Sirolimus (Rapamycin) in an Ex Vivo Model of Thyroid Eye DiseaseJonathan C P Roos, Viesturs Eglitis, Rachna Murthy
Eye (London, England)|September 30, 2023
Comment on: Epimax-related ocular surface toxicity (EROST): the Glasgow experienceAmy Gallant Sullivan, Rachna Murthy, Jonathan C P Roos
American Journal of Ophthalmology|December 4, 2003
Acquired external punctal stenosis: etiology and associated findingsMohsen Bahmani Kashkouli, Bijan Beigi, Rachna Murthy, et al.
Ophthalmology|April 29, 2008
Fornix fat prolapse as a sign for involutional entropionBijan Beigi, Mohsen Bahmani Kashkouli, Andrew Shaw, et al.
The New England Journal of Medicine|May 14, 2020
Teprotumumab for Active Thyroid Eye DiseaseJonathan C P Roos, Hanna I Hyry, Rachna Murthy
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Eye (London, England)|February 14, 2019
Sirolimus (rapamycin) for the targeted treatment of the fibrotic sequelae of Graves' orbitopathyJonathan C P Roos, Rachna Murthy
Eye (London, England)|December 14, 2018
Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United KingdomJonathan C P Roos, Rachna Murthy
Korean Journal of Ophthalmology : KJO|April 20, 2023
Thyrotropin Receptor Autoantibody Assessment in Thyroid Eye Disease: Does the Assay Type Matter?Malik Moledina, Jonathan Roos, Rachna Murthy
Current Opinion in Ophthalmology|July 18, 2019
Update on the clinical assessment and management of thyroid eye diseaseJonathan C P Roos, Rachna Murthy
Eye (London, England)|November 8, 2018
Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomyJonathan C P Roos, Vignesh Paulpandian, Rachna Murthy
Ophthalmic Plastic and Reconstructive Surgery|November 25, 2020
Inhibition of Fibrotic Contraction by Sirolimus (Rapamycin) in an Ex Vivo Model of Thyroid Eye DiseaseJonathan C P Roos, Viesturs Eglitis, Rachna Murthy
Eye (London, England)|September 30, 2023
Comment on: Epimax-related ocular surface toxicity (EROST): the Glasgow experienceAmy Gallant Sullivan, Rachna Murthy, Jonathan C P Roos
American Journal of Ophthalmology|December 4, 2003
Acquired external punctal stenosis: etiology and associated findingsMohsen Bahmani Kashkouli, Bijan Beigi, Rachna Murthy, et al.
Ophthalmology|April 29, 2008
Fornix fat prolapse as a sign for involutional entropionBijan Beigi, Mohsen Bahmani Kashkouli, Andrew Shaw, et al.
The New England Journal of Medicine|May 14, 2020
Teprotumumab for Active Thyroid Eye DiseaseJonathan C P Roos, Hanna I Hyry, Rachna Murthy
Pageof 3